Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ni-Chun Tsai

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
The American Surgeon|October 25, 2006
Factors affecting survival in patients with anal melanomaYale D Podnos, Ni-Chun Tsai, David Smith, et al.
Leukemia & Lymphoma|October 17, 2018
Antithrombin supplementation did not impact the incidence of pegylated asparaginase-induced venous thromboembolism in adults with acute lymphoblastic leukemiaJason Chen, Dat Ngo, Ibrahim Aldoss, et al.
Hematological Oncology|March 2, 2016
Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixaforShan Yuan, Joycelynne M Palmer, Ni-Chun Tsai, et al.
The Oncologist|March 8, 2023
A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation TherapySaro Kasparian, Oren Wei, Ni-Chun Tsai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 2010
HIV status does not affect the outcome of autologous stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL)Amrita Krishnan, Joycelynne M Palmer, John A Zaia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 6, 2016
Cytogenetics Does Not Impact Outcomes in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell TransplantationIbrahim Aldoss, Ni-Chun Tsai, Marilyn L Slovak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 2, 2011
Matched-cohort analysis of autologous hematopoietic cell transplantation with radioimmunotherapy versus total body irradiation-based conditioning for poor-risk diffuse large cell lymphomaAmrita Krishnan, Joycelynne M Palmer, Ni-Chun Tsai, et al.
Blood|May 22, 2012
Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphomaRobert Chen, Joycelynne M Palmer, Sandra H Thomas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2011
High-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factorsAuayporn Nademanee, Joycelynne M Palmer, Leslie Popplewell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2014
Brentuximab vedotin is associated with improved progression-free survival after allogeneic transplantation for Hodgkin lymphomaRobert Chen, Joycelynne M Palmer, Ni-Chun Tsai, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
The American Surgeon|October 25, 2006
Factors affecting survival in patients with anal melanomaYale D Podnos, Ni-Chun Tsai, David Smith, et al.
Leukemia & Lymphoma|October 17, 2018
Antithrombin supplementation did not impact the incidence of pegylated asparaginase-induced venous thromboembolism in adults with acute lymphoblastic leukemiaJason Chen, Dat Ngo, Ibrahim Aldoss, et al.
Hematological Oncology|March 2, 2016
Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixaforShan Yuan, Joycelynne M Palmer, Ni-Chun Tsai, et al.
The Oncologist|March 8, 2023
A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation TherapySaro Kasparian, Oren Wei, Ni-Chun Tsai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 2010
HIV status does not affect the outcome of autologous stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL)Amrita Krishnan, Joycelynne M Palmer, John A Zaia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 6, 2016
Cytogenetics Does Not Impact Outcomes in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell TransplantationIbrahim Aldoss, Ni-Chun Tsai, Marilyn L Slovak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 2, 2011
Matched-cohort analysis of autologous hematopoietic cell transplantation with radioimmunotherapy versus total body irradiation-based conditioning for poor-risk diffuse large cell lymphomaAmrita Krishnan, Joycelynne M Palmer, Ni-Chun Tsai, et al.
Blood|May 22, 2012
Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphomaRobert Chen, Joycelynne M Palmer, Sandra H Thomas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2011
High-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factorsAuayporn Nademanee, Joycelynne M Palmer, Leslie Popplewell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2014
Brentuximab vedotin is associated with improved progression-free survival after allogeneic transplantation for Hodgkin lymphomaRobert Chen, Joycelynne M Palmer, Ni-Chun Tsai, et al.
Pageof 4